Change Lives, Participate in a Clinical Trial, And Get Paid

It’s your involvement that helps improve treatments and access to innovative care for all patients. Find paid clinical trials in Louisville KY at Butchertown Clinical Trials.

Partners / Sponsors – Learn More Patients – View Open Trials

Located Near Downtown Louisville, KY, in Butchertown

1536 Story Ave
Louisville, KY 40206
Call (502) 219-7700

Office hours:
Mon – Fri: 8 AM – 5 PM EST
Sat – Sun: Closed

FDA Approvals
Clinical Trials
Years of Principal Investigator Experience
Trialed Medical Conditions
bct building

About Butchertown Clinical Trials

Butchertown Clinical Trials is a clinical trials research site in Louisville, KY, specializing in ophthalmic, vaccine, adult medicine, and metabolic disease clinical trials. Our mission is to help improve treatments and access to innovative care for all patients by involving them in clinical trials. We regularly recruit study subjects for paid clinical trials sponsored by pharmaceutical companies and medical equipment firms to prove the usefulness of new treatments, surgical implants, or diagnostic medical devices.

Learn More

How We Do Dry Eye Research and Paid Clinical Trials in Louisville, KY

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

How Does It Work?
dry eye research

We are always enrolling for our clinical research trials and studies for:

  • Dry Eye Disease
  • Cataract
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Corneal Dystrophy
  • Geographic Atrophy
  • LASIK and post-operative conditions
  • Conjunctivitis
  • Conditions of the Eye and Ocular Adnexa
  • Environmental Allergies
  • Seasonal Allergies
  • Presbyopia
  • Hypertension
  • Hypothyroid
  • High Cholesterol
  • Nutrition and Weight Loss
  • Type I and Type II Diabetes

New Posts From the Blog

Butchertown Clinical Trials Promotes Kellye Johnson to Clinical Trials Site Director

For Immediate Release Louisville, Kentucky January 13, 2022. Butchertown Clinical Trials, an outpatient clinical trials site, today announced the promotion of Kellye Johnson to Clinical Trials Site Director. She will have the overall responsibility for site workflow and resources management. Kellye has been integral to our development during the past five years, and we are thrilled to promote her to…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 15th FDA Approval Vuity™, the first and only eye drop approved for daily correction of near and intermediate vision without affecting distance vision A First for Our Clinical Trials Program Third Approval in Fifteen Days

For Immediate Release Allergan, an AbbVie company announced the U.S. Food and Drug Administration (FDA) has approved VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. Allergan states “VUITY is the first and only FDA-approved eye drop to treat this common and progressive eye condition that affects 128 million Americans, nearly…

The Ideal Clinical Trials Research Site

Mark Prussian – CEO Mark M. Prussian is a board-certified healthcare administrator and Chief Executive Officer of The Eye Care Institute. Prussian has served as CEO since 1995 and is responsible for all non-clinical matters at The Eye Care Institute including strategic planning and growth, personnel, training, budgeting, managed care, billing, contracts, purchasing, IT and computers, advertising, real estate, optical,…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 14th FDA Approval Tyrvaya™, the first and only nasal spray approved for signs and symptoms of Dry Eye Disease – Second Announcement in Two Days

October 19, 2021 For Immediate Release Oyster Point Pharma, a Princeton NJ company, has announced the FDA has approved Tyrvaya™ as the first and only nasal spray approved for treating signs and symptoms of Dry Eye Disease. Guruprasad R. Pattar, MD, PhD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator for the clinical trials leading…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 13th FDA Approval Dextenza®, physician-inserted eye allergy treatment lasting up to 30 days

October 18, 2021 For Immediate Release Ocular Therapeutix, a Bedford MA company, has announced the FDA has approved Dextenza® for treating ocular itching associated with allergic conjunctivitis. John C. Meyer, MD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator for the clinical trials leading to the FDA approval of this new treatment option for persons…

Health care research facility opens in Butchertown

The Eye Care Institute opened a new research facility on its Butchertown campus. Butchertown Clinical Trials, a division of the Eye Care Institute, announced Friday that the $1.8 million stand-alone clinical trials facility opened at 205 N. Spring Street. It will house eight ongoing clinical trials, according to a news release. Louisville Business First reported in January 2020 that the Eye Care…

Receive Announcements on Upcoming Research Trials

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

Get Started Today

We regularly recruit patients (study subjects) to enroll in clinical trials sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices. View open trials today.

Contact Us